The capsule endoscopy market is expected to grow from USD 605.969 million in 2025 to USD 821.108 million in 2030, at a CAGR of 6.26%.
Capsule endoscopy involves a vitamin-sized capsule equipped with a wireless camera, video chips, light bulb, battery, and radio transmitter, which captures thousands of images of the digestive tract as it passes through. This non-invasive procedure aids in diagnosing gastrointestinal complications, inflammatory bowel diseases (IBD), celiac disease, polyps, esophageal issues, and abnormal tissue growth, particularly where traditional endoscopy is less effective. The technology supports faster recovery and provides a minimally invasive alternative for detecting conditions like obscure gastrointestinal bleeding (OGIB), Crohn’s disease, and small intestine tumors.
The shift toward minimally invasive procedures further accelerates market growth. Capsule endoscopy offers rapid, reliable results for diagnosing conditions like OGIB, Crohn’s disease, and small intestine tumors, boosting its adoption over traditional methods like double-balloon endoscopy. Strategic alliances, such as partnerships and acquisitions, also enhance market penetration. For example, in 2020, Medtronic partnered with Amazon to deliver its PillCam Genius capsule endoscope directly to patients, improving global access and patient satisfaction. Additionally, ongoing research and development in capsule-based endoscopic technologies continue to drive innovation and market growth.
The capsule endoscopy market is driven by an aging population, increasing gastrointestinal disorders, and a shift toward minimally invasive diagnostics. Strategic partnerships and R&D advancements further propel growth, particularly in the OGIB and Crohn’s disease segments. However, addressing procedural risks and the lack of trained professionals remains critical for sustained market expansion.
Capsule endoscopy involves a vitamin-sized capsule equipped with a wireless camera, video chips, light bulb, battery, and radio transmitter, which captures thousands of images of the digestive tract as it passes through. This non-invasive procedure aids in diagnosing gastrointestinal complications, inflammatory bowel diseases (IBD), celiac disease, polyps, esophageal issues, and abnormal tissue growth, particularly where traditional endoscopy is less effective. The technology supports faster recovery and provides a minimally invasive alternative for detecting conditions like obscure gastrointestinal bleeding (OGIB), Crohn’s disease, and small intestine tumors.
Market Growth Drivers
The capsule endoscopy market is poised for growth due to several key factors. The rising geriatric population significantly drives demand, as aging increases the risk of gastrointestinal disorders such as IBD, Crohn’s disease, and colorectal cancer. The growing prevalence of these conditions, coupled with increased adoption of screening tests, fuels market expansion. For instance, the American Cancer Society projected approximately 1.9 million cancer cases in the U.S. for 2022, highlighting the need for advanced diagnostics like capsule endoscopy.The shift toward minimally invasive procedures further accelerates market growth. Capsule endoscopy offers rapid, reliable results for diagnosing conditions like OGIB, Crohn’s disease, and small intestine tumors, boosting its adoption over traditional methods like double-balloon endoscopy. Strategic alliances, such as partnerships and acquisitions, also enhance market penetration. For example, in 2020, Medtronic partnered with Amazon to deliver its PillCam Genius capsule endoscope directly to patients, improving global access and patient satisfaction. Additionally, ongoing research and development in capsule-based endoscopic technologies continue to drive innovation and market growth.
Segment Analysis
The OGIB segment dominates the market due to capsule endoscopy’s advantages, including real-time visualization, comprehensive small intestine imaging, and precise diagnostics. The trend toward capsule-based screening for OGIB, compared to conventional methods, supports this segment’s growth. Similarly, the Crohn’s disease segment is expected to grow substantially, driven by the rising prevalence of IBD. In Canada, for instance, Crohn’s and Colitis Canada reported approximately 260,000 people living with IBD in 2021, with projections estimating a 50% increase in prevalence by 2030, reaching around 400,000 cases. This rising incidence underscores the growing demand for capsule endoscopy in detecting Crohn’s disease and other IBD-related conditions.Challenges
Despite its growth potential, the capsule endoscopy market faces challenges, including risks and complications associated with the procedure, such as capsule retention, and a shortage of skilled physicians trained in its use. These hurdles may hinder widespread adoption and require targeted efforts to address through training and technological advancements.The capsule endoscopy market is driven by an aging population, increasing gastrointestinal disorders, and a shift toward minimally invasive diagnostics. Strategic partnerships and R&D advancements further propel growth, particularly in the OGIB and Crohn’s disease segments. However, addressing procedural risks and the lack of trained professionals remains critical for sustained market expansion.
Key Benefits of this Report:
- Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
- Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
- Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
- Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
- Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive IntelligenceReport Coverage:
- Historical data from 2022 to 2024 & forecast data from 2025 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others).
Capsule Endoscopy Market Segmentation
By Component
- Sensors
- Data Recorder & Work Stations
By Product
- Small Bowel Capsule
- Esophageal Capsule
- Colon Capsule
By Application
- Obscure Gastrointestinal Bleeding
- Crohn’s Disease
- Intestine Disease
- Others
By End-User
- Hospital
- Clinics
- Others
By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Isreal
- Others
- Asia Pacific
- China
- Japan
- South Korea
- India
- Indonesia
- Thailand
- Taiwan
- Others
Table of Contents
1. EXECUTIVE SUMMARY4. TECHNOLOGICAL OUTLOOK
2. MARKET SNAPSHOT
3. BUSINESS LANDSCAPE
5. CAPSULE ENDOSCOPY MARKET BY COMPONENT
6. CAPSULE ENDOSCOPY MARKET BY PRODUCT
7. CAPSULE ENDOSCOPY MARKET BY APPLICATION
8. CAPSULE ENDOSCOPY MARKET BY END-USER
9. CAPSULE ENDOSCOPY MARKET BY GEOGRAPHY
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
11. COMPANY PROFILES
12. APPENDIX
Companies Mentioned
- JInshan Science & Technology (Group) Co. Ltd
- IntroMedic
- Olympus Corporation
- CapsoVision Inc.
- Medtronic Plc.
- RF Co., Ltd.
- Steris Corporation
- BioCam
- AnX Robotics.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 148 |
Published | June 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 605.97 Million |
Forecasted Market Value ( USD | $ 821.11 Million |
Compound Annual Growth Rate | 6.2% |
Regions Covered | Global |
No. of Companies Mentioned | 9 |